Amcor opens $35 million healthcare coating plant in Malaysia to speed sterile packaging output

Amcor has opened a new healthcare packaging coating facility in Subang Jaya, Malaysia, in a $35 million investment that brings air-knife coating technology to Southeast Asia. The site is set up to produce coated medical paper used in sterile medical device packaging, adding regional capacity in a segment where coating uniformity and supply reliability directly affect manufacturing flow.

Air-knife coating moves closer to regional customers

The company said the facility is designed as a fully integrated manufacturing site for healthcare packaging, not just a standalone line. That matters because the new plant gives Amcor a local base for dual sourcing, pilot-to-production scale-up and faster technical collaboration with customers in the region.

By localizing coated medical paper production in Malaysia, the company is aiming to reduce lead times and improve supply chain resilience for healthcare customers across Asia Pacific. The opening also expands Amcor’s manufacturing footprint beyond its existing healthcare packaging operations in the market.

What the Malaysian plant adds to sterile packaging production

The new site introduces advanced inspection, automated manufacturing, closed-loop process controls and in-line quality monitoring. Amcor said those systems are intended to support consistency in coated medical paper, where process stability is critical for sterile packaging applications.

The company also said U.S.-based technical specialists worked with the Malaysian team on installation, commissioning and operational training. That transfer is a practical signal that the plant is being treated as an advanced manufacturing platform rather than a simple capacity addition.

A broader push to build local healthcare packaging capacity

Amcor framed the opening as part of a larger push to strengthen Malaysia’s role as a regional hub for healthcare packaging. The company said the investment aligns with the country’s push to attract high-value manufacturing and supports faster commercialization for regional customers needing coated materials for sterile device packaging.

For healthcare supply chains, the main significance is straightforward: the coating process that once depended more heavily on imported capacity now has a new production base in Southeast Asia, with the ability to support closer, faster and more localized packaging supply.